Home >> Investments >> Edwards Lifesciences
AF. Bauer 2016 Investments
 Call +41435081899
  info@AF. Bauer.com
Edwards Lifesciences (NYSE:EW)

Status:
Bought in:
Sold out:


Holding
10th March 2016 at $87.63 per share
30th September 2016 $120.56



Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company manufactures heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. It develops hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Company conducts operations around the world and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease. The Company's products and technologies it offers to treat advanced cardiovascular disease are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.

Previous   Next >
Page: 4 of 9
Andreas F Bauer, a Dutch Investment Firm , Licensed and Authorised by the Dutch Authority for Financial Markets (AFM), under license number 12042561

© 2018 AF. Bauer All Rights Reserved.

Vienna Twin Tower, Wienerbergstraße 11, 1100 Wien, Austria